Standard BioTools Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 28.19 million compared to USD 27.02 million a year ago. Net loss was USD 19.78 million compared to USD 20.85 million a year ago.

Basic loss per share from continuing operations was USD 0.25 compared to USD 0.26 a year ago.